BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17499311)

  • 1. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo.
    Fang L; Moore XL; Gao XM; Dart AM; Lim YL; Du XJ
    Life Sci; 2007 May; 80(23):2154-2160. PubMed ID: 17499311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
    Xu X; Su YL; Shi JY; Lu Q; Chen C
    Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candesartan cilexetil attenuated cardiac remodeling by improving expression and function of mitofusin 2 in SHR.
    Wang Z; Niu Q; Peng X; Li M; Liu K; Liu Y; Liu J; Jin F; Li X; Wei Y
    Int J Cardiol; 2016 Jul; 214():348-57. PubMed ID: 27085127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
    Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
    J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.
    Yu H; Guo Y; Mi L; Wang X; Li L; Gao W
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):205-11. PubMed ID: 21106870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene
    Sun D; Li C; Liu J; Wang Z; Liu Y; Luo C; Chen Y; Wen S
    DNA Cell Biol; 2019 Aug; 38(8):796-807. PubMed ID: 31295012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of cardiac hypertrophy by mitofusin 2 in neonatal rat cardiomyocytes].
    Chen CL; Shen T; Zheng M; Guo YH; Zhu XJ; Chen GH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):528-32. PubMed ID: 18931719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.
    Li XX; Zhang P; Yang Y; Wang JJ; Zheng YJ; Tan JL; Liu SY; Yan YM; Zhang YY; Cheng YX; Yang HT
    Acta Pharmacol Sin; 2022 Mar; 43(3):588-601. PubMed ID: 33967278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy.
    Zhao Y; Ponnusamy M; Liu C; Tian J; Dong Y; Gao J; Wang C; Zhang Y; Zhang L; Wang K; Li P
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2871-2881. PubMed ID: 28782654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The regulatory mechanism of Raf/MEK/ERK pathway on the rat cardiac hypertrophy induced by transverse aortic constriction].
    Fu DT; Tu J; Cai YQ; Cai ZW; Zhang LZ; Liu JY; Xu SC; Wang DJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jan; 36(1):33-38. PubMed ID: 32476371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression.
    Nie X; Fan J; Wang Y; Xie R; Chen C; Li H; Wang DW
    Front Med; 2024 Jun; 18(3):484-498. PubMed ID: 38743133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression.
    Chen H; Du Y; Li Y; Zeng J; Miao J; Jiang X
    J Tradit Chin Med; 2019 Jun; 39(3):346-355. PubMed ID: 32186007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro.
    Pawlikowska P; Gajkowska B; Orzechowski A
    Cell Tissue Res; 2007 Mar; 327(3):571-81. PubMed ID: 17093923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phorbol ester on the release of atrial natriuretic peptide from the hypertrophied rat myocardium.
    Kinnunen P; Taskinen T; Järvinen M; Ruskoaho H
    Br J Pharmacol; 1991 Feb; 102(2):453-61. PubMed ID: 1826618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin affects vascular smooth muscle cell proliferation and apoptosis through modulation of the mitofusin-2-mediated Ras-Raf-Erk1/2 signaling pathway.
    Zhang W; Shu C; Li Q; Li M; Li X
    Mol Med Rep; 2015 Sep; 12(3):4703-4707. PubMed ID: 26059448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase inhibition reverses impaired Ca
    Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.